homeCompanyServicesResearchEventsContactStoreApplyLogin
Summary
Key Questions
Who Will Benefit From This Research?
Contents
Excerpt
Research & Advisory Membership
Agbiotech 2005 Order Form

Agbiotech 2005:

Regional Trends in Adoption and Acceptance

A bio-era Special Report (available for $250.00 US)

Agricultural Biotechnology 2005: Regional Trends in Adoption and Acceptance (55 pp., 24 figures) is an authoritative and unique report providing bio-era's independent assessment of recent developments affecting the adoption and acceptance of agricultural biotechnology on a region by region basis around the world, and the business outlook for GM crops going foward within each regional market. The report evaluates commercial, technical, and regulatory factors that characterize the business environment for each of five regions:  Asia-Pacific, Latin America, Africa, Europe and North America, and for key countries within Africa, Asia, and Latin American, including:

Latin America

Africa

Asia-Pacific

Brazil

Egypt

Australia

Paraguay

Kenya

India

Mexico

South Africa

China

Argentina

Uganda

Thailand

Zambia

Japan
Phillipines

Regions and key countries are evaluated with respect to:

  • Availability of GM crops to meet local requirements
  • Government support for research and development in agricultural biotechnology
  • Intellectual property regimes
  • Consumer acceptance levels
  • GM crop approvals
  • Regulations restricting GM products.

The landscape of key institutions (NGO's, industry associations, government agencies, companies, and others) in Africa, Asia-Pacific, and Latin America who are actively seeking to influence the debate on biotech crop adoption within key regional countries is also provided, along with hyperlinks to the institutions websites, and bio-era's perspective on where they currently stand.  

Key questions to be answered:

  • What is the current situation with respect to the adoption and acceptance of GM crops in key regions around the world, including Africa, Latin America, Asia-Pacific, Europe, and North America?
  • What is the business environment outlook for GM crops in key countries within each of these regions?
  • What is the legislative and regulatory situation in each region, and in key countries within each region?
  • Who are the influential participants in the debate around GM Crops within key regional countries, and where do they stand?
  • What are the key trends and leading indicators, and where is the global GM crop debate headed?

Who will benefit from this research?

  • Agbiotech industry executives in marketing, business development, planning, technology acceptance, public eduction, and issues management
  • Public and private investors in agricultural biotechnology
  • NGO managers active around the issue of genetically modified crops
  • Developing country regulators and legislators involved in crafting GM crop laws and regulations 
  • OECD regulators and government officials involved in agricultural biotechnology

Contents:

Executive Summary

Latin America: New Legal and Commercial Structures Emerge
Legislative Developments
Royalty Payment Agreements
Mexico's GM Maize Controversy
Outlook

Asia: Tipping the Balance Toward Adoption of GM Rice?
China: A Future Biotech Powerhouse?
India: Biotech Takes Off
Philippines: Gateway into Asia?
Thailand: Contamination Controversy
Japan: Consolidation of GMO Opposition
Australia: New Varieties Under Testing and Cultivation

Africa: New Legislation and Regulation Comes into Place
Biosafety Legislation in Africa
Bioprospecting Concerns
Country Support for GM Crops and Biotech Development
Outlook

North America: A Shifting Competitive Landscape
Legislative Developments
Monsanto Defers GM Wheat Introduction
Increased Demand for Stacked Traits
Persistent Interest in Plant-based Pharmaceutical Production
Industry Restructuring and Acquisitions
Prospects for Open Source Biology
Outlook

Europe: “Cat and Mouse” with the Member States
New Crop Approvals in the EU
New EU Rules for Segregation
Syngenta Quits Europe
ENTRANSFOOD Publishes Conclusions
Outlook

Notes

Excerpt from the Executive Summary

“The year 2005 is a momentous one for agricultural biotechnology around the world. While neither the biotechnology industry nor opponents of genetically modified (GM) crops can claim unqualified victories, the underlying reality is that new legislation, regulations, and commercial agreements are coming into place this year in many key countries that will set the framework within which the industry will operate in the coming years.”

from the Executive Sumary
Agbiotech 2005



Click here to enroll or get more info.

top